Neuroone Medical Technologies (NMTC) Capital Expenditures Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 1,114.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,114.63% |
| Dec 31, 2025 | 66.92% |
| Sep 30, 2025 | -71.26% |
| Jun 30, 2025 | 194.22% |
| Mar 31, 2025 | -89.89% |
| Dec 31, 2024 | -34.24% |
| Sep 30, 2024 | -35.95% |
| Jun 30, 2024 | -89.37% |
| Mar 31, 2024 | -82.15% |
| Dec 31, 2023 | 222.54% |
| Sep 30, 2023 | -12.94% |
| Jun 30, 2023 | 156.83% |
| Mar 31, 2023 | 88.27% |
| Dec 31, 2022 | -81.28% |
| Sep 30, 2022 | 88.50% |
| Jun 30, 2022 | 81.32% |
| Sep 30, 2021 | -37.70% |
| Jun 30, 2021 | 15.74% |
| Sep 30, 2020 | 193.00% |
| Jun 30, 2020 | -52.10% |